Trump Sounds Alarm Over Prescription Drug Prices
Trump administration defends Medicare drug price talks in case brought by Novartis
The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate prescription drug prices, a sign that some consumer advocates said suggests the Trump administration is willing to maintain the controversial program.
Money Talks News on MSN6h
Fixed Income, Rising Costs: Medicare Patients Face Skyrocketing Drug PricesMedicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.
The bill would tie prescription drug prices to federally negotiated rates under a program passed in the 1990s.
A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...
Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker ...
Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...
House Democrats beat back a series of Republican amendments on party-line votes Wednesday, setting up a final vote on a ...
Less than two months after the new law went into effect, drug cases filed in court outnumber theft cases by 3 to 1.
The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback